The official in charge of federal food and drug safety inspections will retire May 14. Michael Rogers, associate commissioner for inspections and investigations at the U.S. Food and Drug Administration (FDA), announced his decision Monday in an email to colleagues. “I have decided to retire. It was my decision, but it was time after 34 years,” Rogers told CBS News in an email. His departure comes at a time of many concerns within the agency. Some staff members say they are frustrated with the direction of inspections under new FDA Commissioner Dr. Marty Makary. Rogers led inspection efforts during the 2022 infant formula crisis, when the FDA was criticized for its slow response to problems at an infant formula plant linked to a deadly recall. He also led a reorganization of the inspections office last year, CBS News reported. Two FDA officials told CBS News that Rogers had recently shared with coworkers that he was unhappy at work. Their comments were made anonymously. They said that recent staffing cuts ordered by U.S. Health Secretary Robert F. Kennedy Jr. have already made it harder for the inspections team to keep up with demands. At the same time, Makary has promised to expand surprise foreign inspections. On Monday, he said at a White House event that the FDA would also shorten the length of foreign trips. “We’re…  read on >  read on >

The official in charge of federal food and drug safety inspections will retire May 14. Michael Rogers, associate commissioner for inspections and investigations at the U.S. Food and Drug Administration (FDA), announced his decision Monday in an email to colleagues.  “I have decided to retire. It was my decision, but it was time after 34 years,” Rogers told CBS News in an email. His departure comes at a time of many concerns within the agency. Some staff members say they are frustrated with the direction of inspections under new FDA Commissioner Dr. Marty Makary. Rogers led inspection efforts during the 2022 infant formula crisis, when the FDA was criticized for its slow response to problems at an infant formula plant linked to a deadly recall. He also led a reorganization of the inspections office last year, CBS News reported. Two FDA officials told CBS News that Rogers had recently shared with coworkers that he was unhappy at work. Their comments were made anonymously.  They said that recent staffing cuts ordered by U.S. Health Secretary Robert F. Kennedy Jr. have already made it harder for the inspections team to keep up with demands. At the same time, Makary has promised to expand surprise foreign inspections. On Monday, he said at a White House event that the FDA would also shorten the length of foreign trips. “We’re…  read on >  read on >

What your child eats could play a role in when they start puberty, a new study shows. Researchers found that girls who ate more inflammatory foods were 15% more likely to get their first period in the next month. On the other hand, a healthier diet lowered the odds by 8%. The findings were published May 6 in the journal Human Reproduction. An early first period is more than just a milestone. It’s linked to a higher risk of breast cancer, heart disease and diabetes later in life, said study author Holly Harris, an epidemiologist at Fred Hutch Cancer Center in Seattle. “This may be an important time period for lowering risk of chronic diseases that occur in adulthood,” Harris told CNN. The study included more than 7,500 children ages 9 to 14 from the Growing Up Today Study. Researchers looked at their diets using two indexes: one gauging how foods and nutrients predict chronic disease, and another considering how inflammatory a diet was. “Eating a healthy diet in late childhood and early adolescence is associated with girls having a later first period compared to those consuming a less healthy diet. Importantly, this association was not explained by the impact of diet on body size,” Harris said. When body mass index (BMI), an estimate of body fat based on height and weight, was factored in,…  read on >  read on >

What your child eats could play a role in when they start puberty, a new study shows. Researchers found that girls who ate more inflammatory foods were 15% more likely to get their first period in the next month. On the other hand, a healthier diet lowered the odds by 8%. The findings were published May 6 in the journal Human Reproduction. An early first period is more than just a milestone. It’s linked to a higher risk of breast cancer, heart disease and diabetes later in life, said study author Holly Harris, an epidemiologist at Fred Hutch Cancer Center in Seattle. “This may be an important time period for lowering risk of chronic diseases that occur in adulthood,” Harris told CNN. The study included more than 7,500 children ages 9 to 14 from the Growing Up Today Study. Researchers looked at their diets using two indexes: one gauging how foods and nutrients predict chronic disease, and another considering how inflammatory a diet was. “Eating a healthy diet in late childhood and early adolescence is associated with girls having a later first period compared to those consuming a less healthy diet. Importantly, this association was not explained by the impact of diet on body size,” Harris said. When body mass index (BMI), an estimate of body fat based on height and weight, was factored in,…  read on >  read on >

The head of the U.S. Food and Drug Administration (FDA) reiterated Tuesday that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters. Companies applying for approval of COVID boosters are being encouraged to use “gold standard science,” including full-fledged clinical trials involving healthy people, FDA Commissioner Dr. Marty Makary said today at the American Hospital Association’s annual meeting in Washington, D.C. That approach could mean no COVID boosters will be approved in time for next winter’s respiratory disease season, Makary has warned in earlier interviews. “We need some better data. We can’t just extrapolate from a clinical trial from four or five years ago,” he said at the conference. “Americans have a very low uptake and a very low confidence of the COVID boosters right now.” For example, 85% of health care workers did not get the last COVID booster, Makary noted. “It’s reasonable to say we’d like to see a clinical trial rather than just some antibodies that spike after you give [the vaccine],” he said. “You can make antibodies spike to anything. That doesn’t tell us that it actually has a clinical benefit. Americans want to know, do we really, is there really a clinical benefit in healthy subjects?” The FDA also is considering whether COVID boosters should be given primarily to high-risk groups, as opposed…  read on >  read on >